Liver cell injection trial offers hope for cirrhosis patients
Disease control
ENROLLING_BY_INVITATION
This early-stage trial tests a new cell therapy called HCL001 in 39 adults with decompensated cirrhosis, a serious liver condition. The study aims to find a safe dose and see if the treatment can improve liver function over 48 weeks. Participants receive a single injection of cel…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Huicun Medical Technology Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC